K-Cap ODT 25 mg (Tegoprazan)

Adult dose

This medicine is administered to adults as follows. 1. Treatment of erosive gastroesophageal reflux disease Administer 50 mg orally once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, administer for an additional 4 weeks. 2. Treatment of nonerosive gastroesophageal reflux disease Administer 50 mg orally once daily for 4 weeks. 3. Treatment of gastric ulcers Administer 50 mg orally once daily for 8 weeks. 4. Antibiotic combination therapy for Helicobacter pylori eradication in patients with peptic ulcers and/or chronic atrophic gastritis Patients with Helicobacter pylori infection should receive eradication therapy. Administer this medicine 50 mg, amoxicillin 1 g, and clarithromycin 500 mg orally twice daily for 7 days. 5. Maintenance therapy following treatment of erosive gastroesophageal reflux disease <25mg only> Administer 25 mg orally once daily. This medicine may be administered with or without food. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild hepatic impairment according to the Child-Pugh classification. This medicine is an orally disintegrating tablet. Place it on the tongue and allow it to dissolve in saliva before swallowing, or take it with water. If oral administration of this medicine is difficult, place it in a syringe with approximately 10 mL of water, gently shake to disperse, and immediately administer into the stomach through a nasogastric tube. To ensure no residue remains, add an additional 20 mL of water to the syringe and repeat administration through the nasogastric tube.

This medication should not be used in certain patients. Individuals who have allergies or a history of hypersensitivity to this drug or its components, as well as those taking certain antiviral medications, should not take this medication. It is also safe for pregnant or breastfeeding women to avoid using this drug. Patients with severely impaired liver function or kidney function problems should use this medication with caution. Older adults may also have decreased liver or kidney function, so caution is needed. Various side effects may occur while taking this medication, with the most common symptoms being nausea, diarrhea, and dyspepsia. Other symptoms such as headache, dizziness, skin rash, and cough may also occur, so if any unusual symptoms arise, consulting a doctor is advised. Long-term use of this medication may lead to vitamin B12 deficiency, so regular testing is necessary. Long-term use may also increase the risk of gastric polyps or fractures, so taking the minimum duration and dosage necessary is important. Since this medication suppresses gastric acid secretion, there may be a slight increase in the risk of gastrointestinal bacterial infections, so if diarrhea symptoms persist, medical attention should be sought. Additionally, this medication can interact with other drugs, so it should not be taken with certain medications, and if any other medications are being used, it is essential to inform the doctor or pharmacist. Pregnant or breastfeeding individuals should not take this medication, and safety for children and adolescents has not been established, so caution is required. The effects of this drug on driving or operating machinery are unclear, but caution is needed if any unusual symptoms occur. This medication should be stored out of reach of children and should not be transferred to other containers.

Nausea, diarrhea, dyspepsia, pharyngitis, viral upper respiratory infection, chest discomfort, epigastric pain, abdominal discomfort, constipation, abdominal pain, abdominal distension, vomiting, belching, lower abdominal pain, gastric ulcer, anal bleeding, erosive duodenitis, bloating, gastric polyp, gastroesophageal reflux disease, intestinal metaplasia, hematemesis, hemorrhoids, melena, folliculitis, bacterial gastroenteritis, latent tuberculosis, elevated alanine aminotransferase, elevated gamma-glutamyl transferase, increased blood bilirubin, elevated aspartate aminotransferase, increased blood creatine phosphokinase, presence of hematuria, positive urine red blood cells, increased blood gastrin, elevated blood triglycerides, fatigue, ligament sprain, concussion, abrasion, bone fracture, joint damage, muscle strain, myalgia, arthralgia, tendinitis, headache, dizziness, angioedema, dermatitis, seborrheic dermatitis, cough, oropharyngeal pain, throat irritation, vaginal discharge, vulvar pruritus, breast calcifications, adenomyosis, ovarian cyst, bile duct stone, liver cyst, overactive bladder, nocturia, renal cyst, gastric adenocarcinoma, breast cancer, gastrointestinal adenoma, uterine leiomyoma, ventricular ectopic beats, lymphadenitis, anemia, insomnia, dental implant, otalgia, diabetes, hypertension, thyroid cyst, urticaria, taste disturbance, migraine, drowsiness, taste disorder, pruritus, erythema, rash, drug rash, toxic skin rash, pharyngitis, cystitis, herpes zoster, molluscum contagiosum, sinusitis, tonsillitis, myasthenia, chest pain, low back pain, musculoskeletal stiffness, voice disorder, palpitations, flushing, facial flushing, choroiditis, retinal disorders, facial paralysis, sensory abnormalities, cystitis, bronchitis, periodontitis, scoliosis, musculoskeletal discomfort, intervertebral disc disorders of the spine, osteopenia, contusion, pelvic fracture, skin abrasion, dental fracture, wrist fracture, laryngeal ulceration, wet cough, chronic urticaria, diastolic dysfunction, hearing loss, thyroid mass, hepatic steatosis, nephrolithiasis, limb pain

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature to preserve its efficacy for a longer duration.

Appearance

White, convex, round orally disintegrating tablet

Package unit

Bottle - 30 tablets/bottle, PTP - 28 tablets/box [(7 tablets/PTP x 4)]